|
Subcutaneous versus intravenous formulation of trastuzumab for HER2-positive early breast cancer: updated results from the phase III HannaH study |
|
|
|
Title: |
Subcutaneous versus intravenous formulation of trastuzumab for HER2-positive early breast cancer: updated results from the phase III HannaH study |
Author: |
Jackisch, C. Kim, S.-B. Semiglazov, V. Melichar, B. Pivot, X. Hillenbach, C. Stroyakovskiy, D. Lum, B.L. Elliott, R. Weber, H.A. Ismael, G. |
Appeared in: |
Annals of oncology |
Paging: |
Volume 26 () nr. 2 pages 320-325 |
Year: |
2015 |
Contents: |
|
Publisher: |
European Society for Medical Oncology |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|